Obstetric complications are the hallmark of antiphospholipid syndrome. Recurrent
miscarriage, early delivery, oligohydramnios, prematurity, intrauterine growth restriction, fetal …

Antiphospholipid syndrome, a condition characterized by one or more thrombotic or
pregnancy-related clinical features in association with medium to high levels of …

Antiphospholipid syndrome (APS) is a rare condition clinically characterized by thrombotic
events or pregnancy complications and confirmed by one or more repeatedly positive …

APS is among the most frequent acquired risk factors for a treatable cause of recurrent
pregnancy loss and increases the risk of conditions associated with ischaemic placental …

Antiphospholipid syndrome (APS) is an autoimmune disease characterised by the presence
of antiphospholipid antibodies (aPL). The antibodies currently included in the classification …

Antiphospholipid syndrome (APS) in pregnancy has a serious impact on maternal and fetal
morbidity. It causes recurrent pregnancy miscarriage and it is associated with other adverse …

Pregnancy loss is the main obstetrical complication of the obstetric antiphospholipid
syndrome. Classically, such losses have been attributed to placental thrombosis and …

Antiphospholipid antibodies (aPLs) are acquired antibodies directed against negatively
charged phospholipids, a group of inner and outer cell membrane antigens found in …

The medical significance of antiphospholipid antibodies lagged behind the description of the
false-positive serologic test for syphilis and lupus anticoagulant (LA) for at least a decade. In …

Background The optimal treatment of women with primary antiphospholipid syndrome (APS)
is still debated. About 20–30% of women with APS remain unable to give birth to healthy …